Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis) : A systematic review of randomized controlled trials.

CONCLUSIONS: Currently, there is insufficient evidence for recommendation for any cannabinoid preparations for symptom management in patients with chronic pain associated with rheumatic diseases. PMID: 26767993 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26767993?dopt=Abstract

Source: Schmerz - January 14, 2016 Category: Anesthesiology Authors: Fitzcharles MA, Baerwald C, Ablin J, Häuser W Tags: Schmerz Source Type: research